Globalhuman milk oligosaccharides market is expected to reach USD 134.7 million by2022, according to a new report by Grand View Research, Inc. The human milkoligosaccharides industry is expected to witness significant demand owing toincreasing need from infant formula and functional food & beverageapplications.
Numerousplayers have been investing for development of new technologies for commercialscale product manufacturing, thus augmenting growth. For instance, Inbiose N.V.uses fermentation process for commercial scale production of human milkoligosaccharides.
Risingconcern regarding gut health coupled with increasing dairy industry is expectedto augment product demand in dairy and pharmaceutical applications. Changingconsumer lifestyles and shift towards nutritious food is expected to boostproduct need over the forecast period. In addition, issues related to infantmalnutrition and mortality throughout the world is expected to augment productover the next seven years.
View summary of this report @ http://www.radiantinsights.com/research/human-milk-oligosaccharides-market
Further key findings from thereport suggest:
InfantFormula was the largest application, accounting for over 70% of global volumein 2014. High infant mortality rate coupled with increased need of the productfor infants deprived of mother's milk is expected to propel demand.
Functionalfood & beverages are expected to witness rise on account of growingawareness towards gut health. In addition, rapidly growing need for betterhealthcare services and nutritional food products in Asia Pacific and LatinAmerica is expected to fuel growth over the next seven years. The segment isexpected to grow at a CAGR of 17.9% from 2015 to 2022.
Europewas the dominant region in terms of volume, accounting for over 35.0% of thetotal share in 2014 primarily due to growing demand for prebiotic products.Europe human milk oligosaccharides demand is expected to grow at a significantrate owing to regulations promoting use of 2'FL and LNnT in infant formulas.
Read Sample report of this Category: http://www.radiantinsights.com/catalog/personal-care
Theglobal market is consolidated with limited players dominating the industry. Keycompanies present include Inbiose, Elicityl SA, Jennewein Biotechnologie,Glycom, Medolac Laboratories, ZuChem, and Glycosyn. These companies areextensively involved in R&D activities for the product. Moreover, some ofthe players including Glycom A/S are integrated across the value chain, wherethey produce the raw materials used in manufacturing of HMOs.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope &Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. HMO Market - IndustrySummary and Key Buying Criteria, 2012 - 2022
Chapter 3. HMO Industry Outlook
3.1. HMO market segmentation
3.2. HMO market size and growthprospects, 2012 - 2022
3.3. HMO market - Value chainanalysis
3.3.1. Vendor landscape
3.4. Raw material outlook, 2012- 2022
3.5. Technology overview
3.6. Regulatory framework
3.7. HMO market dynamics
3.7.1. Market driver analysis
3.7.2. Market restraint analysis
About Radiant Insights
RadiantInsights is a platform for companies looking to meet their market research andbusiness intelligence requirements. We assist and facilitate organizations andindividuals procure market research reports, helping them in the decisionmaking process. We have a comprehensive collection of reports, covering over 40key industries and a host of micro markets. In addition to over extensivedatabase of reports, our experienced research coordinators also offer a host ofancillary services such as, research partnerships/ tie-ups and customizedresearch solutions.
For More Information, Visit Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
No comments:
Post a Comment